You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor- infiltrating immune cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Circulating and Tumor-infiltrating Immune Cells in Malignant

Recruiting
  • Brain Tumor, Primary
  • Brain Tumor - Metastatic
  • Circulating leukocytes immunophenotype
  • Tumor sampling
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Apr 14, 2023

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial in Tianjin (LM103)

Recruiting
  • Solid Tumor
  • LM103
  • Tianjin, China
    Tianjin Beichen Hospital
Jul 4, 2023

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Immune Checkpoint Inhibitors in Genitourinary Malignancies

Suspended
  • Carcinoma, Renal Cell
  • Carcinoma, Urothelial
  • Immune cell and CTC detection procedures
  • Durham, North Carolina
    Duke University Medical Center
Nov 11, 2022

Solid Tumor Trial (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumor
  • Tumor Infiltrating Lymphocytes
  • +3 more
  • (no location specified)
Dec 11, 2022

Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

Recruiting
  • Oncology
  • moderate Whole Body Hyperthermia (mWBH)
  • Berlin, Germany
    Klinik für Radioonkologie und Strahlentherapie
Apr 6, 2023

Cancer, Solid Tumor, Thromboembolism Trial in Tripoli (Palbociclib, Rivaroxaban, SNP)

Recruiting
  • Cancer
  • +12 more
  • Tripoli, North Lebanon, Lebanon
  • +1 more
Oct 5, 2023

Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))

Completed
  • Melanoma
  • Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2023

Cellular Immunity and Renal Cell Cancer

Completed
  • NK Cell Mediated Immunity
  • +2 more
    • Rijeka, Croatia
      Clinical Hospital Center Rijeka
    Sep 19, 2021

    Epithelial Tumors, Malignant, Malignant Solid Tumor Trial in Barcelona (NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD)

    Recruiting
    • Epithelial Tumors, Malignant
    • Malignant Solid Tumor
    • NEXTGEN-TIL
    • +2 more
    • Barcelona, Spain
      Vall d'Hebron Institute of Oncology
    Nov 25, 2021

    Ovarian Cancer Trial in Roma (Blood sample)

    Recruiting
    • Ovarian Cancer
    • Blood sample
    • Roma, Italy
      Policlinico Universitario Agostino Gemelli
    Oct 10, 2023

    Gastrointestinal Epithelial Cancer, Gastrointestinal Tumors, Cancer of Gastrointestinal Tract Trial in Minneapolis

    Recruiting
    • Gastrointestinal Epithelial Cancer
    • +10 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Aug 20, 2021

    Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

    Active, not recruiting
    • Tumor Skin
    • +2 more
    • OBX-115
    • Orlando, Florida
    • +1 more
    Sep 28, 2023

    Prostate Cancer Trial in Bellinzona (Ruxolitinib 20 MG)

    Withdrawn
    • Prostate Cancer
    • Ruxolitinib 20 MG
    • Bellinzona, Switzerland
      Istituto Oncologico della Svizzera Italiana (IOSI)
    Mar 24, 2020

    Solid Tumor Trial in Suzhou (68Ga-NODAGA-SNA006)

    Recruiting
    • Solid Tumor
    • 68Ga-NODAGA-SNA006
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jul 8, 2022

    Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays

    Not yet recruiting
    • Lung Neoplasm
    • +2 more
    • Tumor samples
    • Bordeaux, France
      CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
    Aug 28, 2023

    Patients Who Respond to Immune Checkpoint Inhibitors to Identify

    Recruiting
    • Solid Tumor, Adult
    • Tumor Biopsy
    • Los Angeles, California
    • +3 more
    Feb 8, 2022

    Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

    Not yet recruiting
    • Advanced Malignant Solid Tumors
    • Neoantigen peptide vaccine
    • Neoantigen-based DC immune preparation
    • Nanchang, Jiangxi, China
      First Affiliated Hospital of Nanchang University
    Mar 1, 2023

    Prognostic Immune Biomarkers in HNSCC

    Completed
    • Head and Neck Cancer
    • Squamous Cell Carcinoma
    • Tumour immunoprofile evaluation
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Jul 3, 2023

    Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

    Recruiting
    • Ependymoma
    • +3 more
    • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
    • Duarte, California
      City of Hope Medical Center
    Mar 9, 2022

    The Immune Landscape of Epithelial Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • Collection of tumor samples, blood and vaginal and rectal swabs
    • Bellinzona, Switzerland
      Oncology Institute of Southern Switzerland
    Aug 2, 2023

    Primarily Resectable Pancreatic Cancer Trial in Heidelberg (neoadjuvant photon radiation)

    Completed
    • Primarily Resectable Pancreatic Cancer
    • neoadjuvant photon radiation
    • Heidelberg, Germany
    • +1 more
    Jun 7, 2021

    Solid Tumor Trial in Shenzhen (bi-4SCAR GD2/PSMA T cells)

    Recruiting
    • Solid Tumor
    • bi-4SCAR GD2/PSMA T cells
    • Shenzhen, Guangdong, China
      Shenzhen Geno-immune Medical Institute
    Jun 25, 2022